| Literature DB >> 36203869 |
Lisanne T Laagland1, Frances C Bach1, Laura B Creemers2, Christine L Le Maitre3, Deepani W Poramba-Liyanage1, Marianna A Tryfonidou1.
Abstract
Background: Repopulating the degenerated intervertebral disc (IVD) with tissue-specific nucleus pulposus cells (NPCs) has already been shown to promote regeneration in various species. Yet the applicability of NPCs as cell-based therapy has been hampered by the low cell numbers that can be extracted from donor IVDs and their potentially limited regenerative capacity due to their degenerated phenotype. To optimize the expansion conditions, we investigated the effects of increasing culture medium osmolarity during expansion on the phenotype of dog NPCs and their ability to produce a healthy extracellular matrix (ECM) in a 3D culture model.Entities:
Keywords: cell‐based therapy; intervertebral disc; lower back pain; nucleus pulposus; osmolarity; regeneration
Year: 2022 PMID: 36203869 PMCID: PMC9520765 DOI: 10.1002/jsp2.1219
Source DB: PubMed Journal: JOR Spine ISSN: 2572-1143
FIGURE 1Expansion in 500 mOsm/L results in polygonal nucleus pulposus cells (NPCs) with a lower cell proliferation rate. (A) Experimental design. (B) Population doubling time of the NPCs during Passage 1 to 2 and 2 to 3 when expanded in normoxia (NX: 21% O2) and hypoxia (HX: 5% O2) in the different media osmolarities (lines indicate the mean ± SD). The black symbols represent female donors and white symbols male donors. *p < 0.05 corrected for multiple testing. (C) Representative brightfield images of NPC morphology at Day 3 of expansion in both NX and HX conditions in the different media osmolarities
Donor details
| Number | Age (years) | Gender | Breed |
|---|---|---|---|
| 1 | 5 | Female | Beagle |
| 2 | 5 | Female | Beagle |
| 3 | 5 | Female | Beagle |
| 4 | 5 | Male | Beagle |
| 5 | 5 | Male | Beagle |
| 6 | 5 | Male | Beagle |
Note: IVDs of beagles >12 months are typically considered to have Thompson grade II–III degeneration. ,
Primer information for reference and target genes
| Genes | Forward sequence 5′ → 3′ | Reverse sequence 5′ → 3′ | Annealing temperature (°C) |
|---|---|---|---|
|
| GCCGGAAGGTTGTAGTCGT | GGAGGAAGGCCAGGTAATTC | 61 |
|
| CCTTCCTCAAAAAGTCTGGG | GTTCTCATCGTAGGGAGCAAG | 61 |
|
| GCCTTGGATCTCTTGATGGA | TTCTTGGCTCTTATGCGATG | 61 |
|
| CTATTTCTTGGTGTGCATGAGG | CCTCGGCATTCAGTCTTTTC | 57 |
|
| GGACACTCCTTGCAATTTGAG | GTCATTCCACTCTCCCTTCTC | 62 |
|
| GCAGCAAGAGCAAGGAC | TTCTGAGAGCCCTCGGT | 62 |
|
| TCCAACGAGATCGAGATCC | AAGCCGAATTCCTGGTCT | 61 |
|
| CTACTGCACAGGGAAGAG | GAACCCATTCCACAAATGTC | 61 |
|
| CTGAGGAAGACTTCCAGCTT | TTGGACCACTTGAGAGTTCG | 65 |
|
| GCCTCGAAGATGAAGGAGAC | CAGTTTGTTCACCAGGAGCA | 60 |
|
| CCTTTTGCTTCAGGGTTTCA | CTCAGCTTCTTGGTGGATGC | 58 |
|
| ATCGCCCTGTGGATGACTGAG | CAGCCAGGAGAAATCAAACAGAGG | 64 |
|
| CGGACTTCTTGTATGCTTACTC | CACAAAGTGACTGGATGAACC | 61 |
|
| CGGAGGGACGCCAAACAGG | GTCCCGGGTCAACTCTTCGTG | 68 |
|
| GAGTTCGTCTTCTCCTTCAACAC | GCTTGATGTCTTGGTAGGTGAC | 58 |
|
| CCTTAGGCGGGTCTCTCGTA | GGGAAGCTGGTGTCTGAGTC | 63 |
|
| TTGCTACCTACCGTCGCCTGTTGG | ATCTTGCGGGTGGTGGTCTTCTGG | 63.5 |
|
| GCCCAGCTGAGCGATGTGC | TGCTCCAGCCGTGACTTGATGT | 64 |
|
| CTAGAGAAATGGTCAACAACTTCC | CACAGATGCCAAGAACGC | 58.5 |
|
| CTGAACTCCTTACATAAGTACGAG | GCTGTGATCTCCTCATTCTG | 62.5 |
|
| CAGCTTACCAGGTGGACATTTTTG | GTCCGCTGGTGCTTGAGATTTAG | 58 |
|
| AATAATATGCCAGAACCCAAAAAG | CCCCAGCCAATATTCACCAGAG | 62 |
|
| GGGACAAATCCAGCAGAAAA | TACAGAGCCTGGAGCTGGTT | 66 |
|
| CTTCTGCAGATCCGAACACA | GAGTAGAAGCCGTTGGATGG | 60 |
|
| CTCCAACACATTCCTTTACAC | ACTCAACCTTCAAATAGCCT | 61 |
|
| CATCCTTCACCACCAAGAG | CAGATTGCAGAAGGACGG | 60 |
|
| TTTATGTACTCAGCCAGCAGG | ATACTTCTTCCTCTCCTTTCACTG | 63.5 |
Antibody and protocol details of immunohistochemistry (first rows) and immunofluorescence (second rows)
| Name | Host | Concentration | Antigen retrieval | Secondary antibody |
|---|---|---|---|---|
| ACAN (ab3778, Abcam) | Mouse | 11.92 μg/ml | Pronase + Hyaluronidase (60 min, 37°C) | Brightvision Poly‐HRP Anti‐Mouse (VWRKDPVM110HRP, Immunologic) |
| 11.92 μg/ml | Triton‐X 100 (0.1%) (60 min, RT) | Goat Anti‐Mouse IgG, Alexa Fluor Plus 488 (A32723, Thermo Fisher Scientific) | ||
| CD24 (LS‐C87657, LSBio) | Mouse | 1:200 (concentration N/A) | 0.01 M citrate buffer pH 6 (60 min, 70°C) | Brightvision Poly‐HRP Anti‐Mouse |
| 1:100 | Triton‐X 100 (0.1%) (60 min, RT) | Goat Anti‐Mouse IgG, Alexa Fluor Plus 488 | ||
| CD73 (LS‐B8284, LSBio) | Rabbit | 0.5 μg/ml | none | BrightVision Poly‐HRP Anti‐Rabbit (VWRKDPVR110HRP, Immunologic) |
| 5 μg/ml | Triton‐X 100 (0.1%) (60 min, RT) | Donkey Anti‐Rabbit IgG, Alexa Fluor 594 (A21207, Thermo Fisher Scientific) | ||
| COL2 (II‐II6B3, Developmental Studies Hybridoma Bank) | Mouse | 0.03 μg/ml | Pronase + Hyaluronidase (30 min, 37°C) | Brightvision Poly‐HRP Anti‐Mouse |
| N/A | ||||
| PAX1 (ab203065, Abcam) | Rabbit | 4 μg/ml | 0.01 M citrate buffer pH 6 (30 min, 70°C) | BrightVision Poly‐HRP Anti‐Rabbit |
| 10 μg/ml | Triton‐X 100 (0.1%) (60 min, RT) | Donkey Anti‐Rabbit IgG Alexa Fluor 594 | ||
| TEK (sc‐324, Santa Cruz Biotechnology) | Rabbit | 4 μg/ml | 0.01 M citrate buffer pH 6 (30 min, 70°C) | BrightVision Poly‐HRP Anti‐Rabbit |
| 4 μg/ml | Triton‐X 100 (0.1%) (60 min, RT) | Donkey Anti‐Rabbit IgG Alexa Fluor 594 |
FIGURE 2Hyperosmolar expansion medium improves the phenotype of dog nucleus pulposus cells (NPCs) independent of oxygen level. (A) Fold changes in relative gene expression of NPC and progenitor markers after expansion of two passages in both normoxic (NX: 21% O2) and hypoxic (HX: 5% O2) conditions in the different media osmolarities (lines indicate the mean + SD). The black symbols represent female donors and white symbols represent male donors. *p < 0.05 corrected for multiple testing. (B) Immunofluorescence images and quantification for ACAN, PAX1, CD24, TEK, and CD73 protein levels following expansion for two passages in the different media osmolarities in HX (lines indicate the mean ± SD). The black symbols represent female donors and white symbols represent male donors. **p < 0.01, ***p < 0.001, #significantly different (p < 0.05) from expansion in HX using the same medium osmolarity corrected for multiple testing
FIGURE 3Hyperosmolar expansion medium maintains healthy ECM production and deposition during 3D culture. (A) GAG and DNA content of the nucleus pulposus cell (NPC) microaggregates at Day 14 of 3D culture (300 mOsm/L; 5% O2) after expansion in both normoxic (NX; 21% O2) and hypoxic (HX; 5% O2) conditions in the different media osmolarities (300, 400, and 500 mOsm/L; lines indicate the mean ± SD). The black symbols represent female donors and white symbols represent male donors (mean of two technical replicates). *p < 0.05, **p < 0.01, ***p < 0.001 corrected for multiple testing. (B) Safranin O/Fast Green and immunohistochemical staining for aggrecan and collagen type II of the NPC microaggregates collected at Day 14 of 3D culture (300 mOsm/L; 5% O2) after expansion in HX conditions in the different media osmolarities
FIGURE 4Nucleus pulposus cells (NPCs) expanded in higher osmolarity retain the expression of healthy phenotypic markers during 3D culture. Immunopositivity for PAX1, CD24, TEK, and CD73 at Day 14 in NPC microaggregates collected at Day 14 of 3D culture (300 mOsm/L; 5% O2) after expansion in hypoxic conditions in the different media osmolarities. Arrows indicate extracellular matrix, cytoplasmic/membranous and arrow heads indicate nuclear localization of immunopositivity.